ÃâÒßѧÊÔÌâ
LqMe'z Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
C+}CU} 1. Fas(CD95)/FasL
&8R-C[A 2. common chain of cytokine receptor
ftDVxKDE?S 3 . TCR/CD3 complex
+>n.T 4. negaive selection of thymocytes
wn&[1gBxM 5. artificial active immune
Ky=(urAd 6. anti-idiotypic
+#&el// 7. IgSF
1uK)1%vK 8. Integrin
*g}vT8w'} 9. chemokine
$IZ*|>( 10. B7/CD28
kfH9Y%bOy ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
@^w!% ?J 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
>b[4 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
(gs`=H*d; 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
i4 y(H 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
t[L2'J.5
;,[EJR^CI 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
bQ${8ZO µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
7lnM|nD Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
{&6l\| 1. B7/CD28
Th I 2. Th1 subset
O&gy( 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
6|>"0[4S 4. antibody affinity maturation
gK] T} 5. AP-1
oW\Q>c7
= 6. single chain variable fragment£¨ScFv£©
fb;hf:B: 7. NK cell receptor
,cl"1>lp 8. Zinkernagel-Doherty phenomenon
?Mgt5by 9. Ig fold
'Gm!Jblo@ 10. CD40/CD40L
kC,D
W%Ls ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
}K qw\]` 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
'RN"yMv7l 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
3oNt]2w/' 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
,sy/rV Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
]2u7?l 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
$$)<(MP3 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
N-_| %C-. 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
E!oJ0*@ Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
!Dhfr{ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
\t7zMp Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
`04Y
;@w 1.Co-stimulators (or co-stimulating molecules)
&nY2u-Q 2.NK-kB
Iclan\q#y 3.Immunoglobulin superfamily
vzgudxG'z 4.antigen-presenting cell (APC)
x,@O:e 5.death domain
g^|_X1{ 6.CCR and CXCR
=V4_DJ(& 7.Lectin (or mitogen)
2* cKFv{ 8.Clusters of differentiation, CD)
;L/T}!Dx 9.B7 family
v\L
Ip 10.Cytotoxic T lymphocyte, CTL)
=,1zl}PR 11.IL-15 and IL-15 receptor (IL-15R)
I(r5\A= 12.MHC restriction
:X'U`jE 13.Affinity-chromatography
.LVOaxT 14.Cyctosprin A, CsA
%#;(]7Zq 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
`5aypJf1 ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
~O3uje
_ 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
mZ.6Njb 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
z 4OR
UQ 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
X+G*Q}5 Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
?.'oxW
ÃâÒßѧרҵ£º
ri_6wbPp 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
L.~]qs|G/K Ïû»¯ÄÚ¿Æ£º
X0J]6|du. 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
x#x
O { ѪҺ²¡Ñ§×¨Òµ£º
|"(3]f\ 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
?
Gu_UW Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
'/)_{Ly (רҵ»ù´¡: ÃâÒßѧ)
Hr.JZ>~< Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
T;e (Q,!H 1. ADCC(antibody dependent cell-mediated cytotoxicity)
m##z 2. »·æß¾úËØ(cyclosporin)
~k_zMU-1 3. KIR(killer cell inhibitory receptor)
:a<TV9?H0 4. HLDA(human leucocyte differentiation antigen)
0BZOr-i 5. Interleukin 18(IL-18)
U@ QU8 6. ÕûºÏËØ(integrin)
79f
yn!Iz< 7. Fas/FasL
:JG}% 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
YuW\GSV00 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
].+G-<.: 10. Th1/Th2
]cY'6'}Hz 11. »ùÒòÒßÃç(DNAÒßÃç)
i3!$M/_] 12. chemokines and chemokine receptor
p%qL0
13. ÃâÒßÄÍÊÜ
NjMLq|X 14. ¹²´Ì¼¤·Ö×Ó
M L_J<|,J 15. ËÀÍö½á¹¹Óò(death domain)
8o!^ZOmU< ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
qMj
e,Y 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
5?Ao9Q]@ 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
?UZyu4O% £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
~}l,H:jk@ £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
VL1z$<vVXt £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
/]>{"sS( £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
,;& PKY 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
q.tL' Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
gVWLY;c 3} ÎÊ´ðÌâ(ÿÌâ25·Ö)
vDb}CQ\ 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
YZJP7nN 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
+N!{(R:"v} 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
{u][q
&n 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£